Sale!

ZFP57 Gene Maturity-onset Diabetes of the Young ZFP57 Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ZFP57 Gene Maturity-onset Diabetes of the Young (MODY) ZFP57-Related Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the ZFP57 gene, which have been associated with a rare form of MODY. Maturity-onset diabetes of the young (MODY) is a group of several conditions characterized by monogenic mutations leading to diabetes that typically manifests in adolescence or early adulthood.

The ZFP57 gene plays a crucial role in the regulation of DNA methylation patterns critical for normal pancreatic development and function. Mutations in this gene can disrupt these processes, leading to the development of diabetes at a young age.

The test is conducted through a blood sample or cheek swab, with DNA Labs UAE utilizing advanced genetic sequencing technologies to accurately detect any mutations in the ZFP57 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed report provided by the lab.

This genetic test is essential for individuals with a family history of MODY or those who exhibit symptoms of diabetes at an unusually young age without the typical risk factors for Type 1 or Type 2 diabetes. Early detection through the ZFP57-Related Genetic Test allows for personalized treatment plans, which can significantly improve management of the condition and overall quality of life.

Description

ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test

Test Name: ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ZFP57 Gene Maturity-onset diabetes of the young, ZFP57 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young, ZFP57 related.

Test Details:

The ZFP57 gene is involved in the development and function of beta cells in the pancreas, which are responsible for producing insulin. Mutations in this gene have been associated with a rare form of diabetes known as maturity-onset diabetes of the young (MODY), specifically MODY type 1.

Maturity-onset diabetes of the young is a monogenic form of diabetes, meaning it is caused by a mutation in a single gene rather than a combination of genetic and environmental factors. MODY is typically diagnosed in young individuals, often before the age of 25, and is characterized by mild hyperglycemia (high blood sugar levels) that is often controlled without the need for insulin treatment.

A ZFP57-related next-generation sequencing (NGS) genetic test is a diagnostic tool used to identify mutations in the ZFP57 gene. This test involves analyzing the individual’s DNA to detect any alterations or variants in the gene sequence that may be associated with MODY type 1.

By identifying mutations in the ZFP57 gene, healthcare professionals can confirm a diagnosis of MODY type 1 and provide appropriate management and treatment strategies. This may include lifestyle modifications, oral medications, or insulin therapy, depending on the severity of the condition.

It is important to note that MODY is a rare form of diabetes, and not all cases are caused by mutations in the ZFP57 gene. There are several other genes associated with different types of MODY, and genetic testing may be used to identify mutations in these genes as well.

Genetic testing can help in accurate diagnosis, genetic counseling, and personalized treatment for individuals with MODY.

Test Name	ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ZFP57 Gene Maturity-onset diabetes of the young, ZFP57 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young, ZFP57 related
Test Details	The ZFP57 gene is involved in the development and function of beta cells in the pancreas, which are responsible for producing insulin. Mutations in this gene have been associated with a rare form of diabetes known as maturity-onset diabetes of the young (MODY), specifically MODY type 1. Maturity-onset diabetes of the young is a monogenic form of diabetes, meaning it is caused by a mutation in a single gene rather than a combination of genetic and environmental factors. MODY is typically diagnosed in young individuals, often before the age of 25, and is characterized by mild hyperglycemia (high blood sugar levels) that is often controlled without the need for insulin treatment. A ZFP57-related next-generation sequencing (NGS) genetic test is a diagnostic tool used to identify mutations in the ZFP57 gene. This test involves analyzing the individual’s DNA to detect any alterations or variants in the gene sequence that may be associated with MODY type 1. By identifying mutations in the ZFP57 gene, healthcare professionals can confirm a diagnosis of MODY type 1 and provide appropriate management and treatment strategies. This may include lifestyle modifications, oral medications, or insulin therapy, depending on the severity of the condition. It is important to note that MODY is a rare form of diabetes, and not all cases are caused by mutations in the ZFP57 gene. There are several other genes associated with different types of MODY, and genetic testing may be used to identify mutations in these genes as well. Genetic testing can help in accurate diagnosis, genetic counseling, and personalized treatment for individuals with MODY.